Primary liver cancer—including hepatocellular carcinoma (HCC) and intrahepatic
cholangiocarcinoma (ICC)—incidence is increasing and is an important source of cancer …

Objective: To review the current management, outline recent advances and address
controversies in the management of hepatocellular carcinoma (HCC). Summary of …

Combined hepatocellular cholangiocarcinoma (CC) is a rare and aggressive primary
hepatic malignancy with significant histological and biological heterogeneity. It presents with …

BACKGROUND: This year, the 7th edition of the AJCC staging manual has for the first time
attributed a unique pTNM staging to intrahepatic cholangiocarcinoma (IHCC) that is …

Intrahepatic cholangiocarcinoma (ICC) is the second most common primary hepatic
malignancy after hepatocellular carcinoma (HCC), accounting for 10% to 15% of primary …

Objective: An evidence-based review to ascertain the operative strategy for oncologic
resection of malignant tumors of the liver and an optimal postoperative outcome …

Abstract Background: Hepatocholangiocarcinoma (HCC-CC) is a rare liver malignancy that
contains features of both hepatocellular carcinoma (HCC) and mass-forming …

Background The role of routine lymph node dissection (LND) in the surgical treatment of
intrahepatic cholangiocarcinoma (ICC) remains controversial. The objective of this study …

Background Combined hepatocellular-cholangiocarcinoma (CHC) is a rare subtype of
primary hepatic malignancies, with variably reported incidence between 0.4%–14.2% of …

Objective: To evaluate the results of surgical therapy for intrahepatic cholangiocarcinoma
(ICC), the incidence and the management of recurrence, and to analyze the change in …